Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan and Ramipril Combination in Stage I or II Hypertension
NCT00281593Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of telmisartan and ramipril in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Apr 2006; status: completed.
02
Drugs
telmisartanramipril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00281593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281593.